Medulloblastomas lacking p53 do not express surface class I major histocompatibility complex (MHC-I) and are resistant to immune rejection. Tumor necrosis factor rescues MHC-I expression and synergizes with immune checkpoint inhibitors to promote rejection.
- Alexandra Garancher
- Hiromichi Suzuki
- Robert J. Wechsler-Reya